AUA 2022 Prostate Cancer - Results from #60

Viewing 61-80 of 91 articles

AUA 2022: AUA Guidelines: Localized Prostate Cancer

AUA 2022: Reliability of 68Ga-PSMA PET/CT in Assessing Real Nodal Burden in Men With cN1 Disease: Clinical Implications for Patient Counselling and Multi-Modal Treatments

AUA 2022: Robot-Assisted PSMA-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe - a Prospective Feasibility Study

AUA 2022: Comparison Between Targeted versus Targeted Plus Standard Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Patients: A Randomized Controlled Trial

AUA 2022: Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates For Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy

AUA 2022: Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer Treated with Enzalutamide or Placebo Plus Androgen Deprivation Therapy Who Had Prior Local Therapy: Post Hoc Analysis of the Phase 3 ARCHES Trial

AUA 2022: Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Results from the Phase 2 QUEST Study

AUA 2022: Comparison of Clinical Outcomes Between Androgen Deprivation Therapy with Up-Front Abiraterone and Bicalutamide for Japanese Patients with LATITUDE High-Risk Prostate Cancer in a Real-World Multicenter Analysis

AUA 2022: Disparities Regarding Shared Decision-Making in Prostate Cancer Screening

AUA 2022: Racial and Ethnic Disparities Magnified After U.S. Preventative Services Task Force Category D Recommendation for PSA Screening

AUA 2022: PSA Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making

AUA 2022: Panel Discussion: What is the Optimal Multidisciplinary Team: Drafting for the Future

AUA 2022: Restaging PSMA PET/CT is Associated with Improved Oncological Outcome in Men Who Underwent Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer

AUA 2022: Immediate Radiotherapy versus Observation in Patients with Node-Positive Prostate Cancer after Radical Prostatectomy

AUA 2022: Best Prostate Biopsy Techniques in 2022

AUA 2022: Comparative Out-of-Pocket Costs of Treatment Options in Privately Insured Patients with Advanced Prostate Cancer

AUA 2022: Practice Patterns in Management of Hormone Sensitive Metastatic and Castrate-Resistant Non-Metastatic Prostate Cancer

AUA 2022: Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer: Detailed Safety Analysis from the Randomized Phase 3 HERO Study

AUA 2022: Long-term Safety of Darolutamide Among Patients With Metastatic Castration-resistant Prostate Cancer Who Received More Than 4 Years of Therapy

AUA 2022: Grade Migration of Prostate Cancer at Diagnosis Following the US Preventive Services Task Force Recommendations on Prostate Cancer Screening

1
2
3
4
5